This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will Innospec (IOSP) Gain on Rising Earnings Estimates?
by Zacks Equity Research
Innospec (IOSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Has Innospec (IOSP) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Innospec (IOSP) and Huntsman (HUN) have performed compared to their sector so far this year.
Innospec (IOSP) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 29.66% and 19.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
LyondellBasell (LYB) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of 14.94% and 3.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Innospec (IOSP) Could Beat Earnings Estimates Again
by Zacks Equity Research
Innospec (IOSP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Innospec (IOSP) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Innospec (IOSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has Allegheny Technologies (ATI) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Allegheny Technologies (ATI) and Innospec (IOSP) have performed compared to their sector so far this year.
Innospec (IOSP) Gets China Approval for Sulfate-Free Surfactants
by Zacks Equity Research
Innospec's (IOSP) technologies, like Iselux, directly deal with increasing long-term consumer demand for clean beauty without compromising product performance.
Innospec (IOSP) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 1.77% and 4.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Innospec (IOSP) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Chemical Stocks Set to Run Higher Despite Supply-Chain Woes
by Anindya Barman
While input cost inflation and supply chain constraints pose headwinds, the chemical industry is expected to benefit from strong demand across major markets. AVNT, MEOH, CC, OLN, IOSP are good options for investment right now.
Why Innospec (IOSP) Might be Well Poised for a Surge
by Zacks Equity Research
Innospec (IOSP) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Innospec (IOSP) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 32.65% and 4.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Innospec (IOSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innospec (IOSP) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 3.92% and 11.34%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Here is Why Growth Investors Should Buy Innospec (IOSP) Now
by Zacks Equity Research
Innospec (IOSP) could produce exceptional returns because of its solid growth attributes.
Dow Inc. (DOW) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Dow Inc. (DOW) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is Why Growth Investors Should Buy Innospec (IOSP) Now
by Zacks Equity Research
Innospec (IOSP) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is Innospec (IOSP) a Profitable Stock to Pick Right Now?
by Zacks Equity Research
Is Innospec (IOSP ) a great pick from the value investor's perspective right now? Read on to know more.
Innospec's (IOSP) Earnings In Line, Revenues Up Y/Y in Q2
by Zacks Equity Research
Innospec (IOSP) saw strong growth in its Oilfield Services segment in the second quarter.
4 Chemical Stocks Worth a Bet Before Their Q2 Earnings
by Anindya Barman
We have shortlisted four chemical stocks that are worth investing in before the Q2 earnings season hits full throttle.
Innospec (IOSP) Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Upbeat prospects for 2019 along with focus on organic growth are driving Innospec's (IOSP) shares.
Air Products (APD) Stock Up 45% YTD: What's Behind the Rally?
by Zacks Equity Research
Upbeat outlook and healthy growth prospects have contributed to the run-up in Air Products' (APD) shares.
Chemicals Witness a Solid Q2 With Strong Production Growth
by Anindya Barman
Global chemicals production rose 0.4% in May, an improvement from a 0.3% gain a month ago.
Innospec (IOSP) Up 40% in 6 Months: What's Driving the Rally?
by Zacks Equity Research
Forecast-topping earnings performance and upbeat prospects have contributed to the rally in Innospec's (IOSP) shares.